Immunofluorescence staining of pancreatic neuroendocrine tumors showed that MCT4 was predominantly expressed in hypoxic tumor compartments and MCT1 was mostly upregulated in MCT4-negative regions. This evidence concerns the gene SLC16A1 and neoplasm.